Bernd Wullich Selected Research

Bernd Wullich Research Topics

Disease

88	Neoplasms (Cancer) 03/2024 - 12/2002
51	Prostatic Neoplasms (Prostate Cancer) 03/2024 - 05/2003
34	Carcinoma (Carcinomatosis) 03/2024 - 01/2006
30	Urinary Bladder Neoplasms (Bladder Cancer) 01/2024 - 12/2002
22	Renal Cell Carcinoma (Grawitz Tumor) 09/2022 - 10/2008
10	Neoplasm Metastasis (Metastasis) 04/2023 - 10/2008
9	Non-Muscle Invasive Bladder Neoplasms 01/2022 - 07/2012
7	Disease Progression 07/2015 - 03/2004
6	Lymphatic Metastasis 10/2019 - 03/2004
4	Hypoxia (Hypoxemia) 01/2022 - 03/2010
4	Carcinogenesis 05/2014 - 03/2006
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022 - 01/2018
3	Margins of Excision 12/2021 - 07/2015
3	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 08/2016 - 05/2003
3	Mastodynia 07/2015 - 08/2012
2	Chronic Kidney Failure (Chronic Renal Failure) 02/2024 - 01/2021
2	Microsatellite Instability 02/2023 - 01/2019
2	Kidney Neoplasms (Kidney Cancer) 01/2022 - 01/2013
2	Circulating Neoplastic Cells 11/2021 - 05/2016
2	Wounds and Injuries (Trauma) 10/2021 - 02/2016
2	Leukemia 01/2019 - 10/2015
2	Adenocarcinoma 01/2016 - 10/2008
2	Residual Neoplasm 07/2012 - 03/2011
2	Seminoma 10/2008 - 11/2006
1	Hypospadias 12/2023
1	Spermatic Cord Torsion (Testicular Torsion) 01/2023

Drug/Important Bio-Agent (IBA)

30	Proteins (Proteins, Gene)FDA Link 03/2024 - 03/2006
19	Messenger RNA (mRNA)IBA 04/2023 - 05/2003
16	Biomarkers (Surrogate Marker)IBA 02/2023 - 02/2012
14	MicroRNAs (MicroRNA)IBA 12/2019 - 04/2010
10	Phenobarbital (Luminal)FDA Link 03/2024 - 01/2017
9	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 01/2006
7	Prostate-Specific Antigen (Semenogelase)IBA 10/2019 - 05/2003
6	ParaffinIBA 01/2022 - 07/2013
6	AntigensIBA 01/2022 - 01/2014
5	Androgen Receptors (Androgen Receptor)IBA 03/2024 - 05/2016
5	AndrogensIBA 03/2024 - 03/2004
5	Formaldehyde (Formol)FDA Link 01/2022 - 07/2013
4	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2019
4	B7-H1 AntigenIBA 01/2023 - 01/2020
4	HLA-G Antigens (HLA G)IBA 01/2020 - 06/2015
4	HLA Antigens (Human Leukocyte Antigens)IBA 05/2017 - 06/2015
3	Hormones (Hormone)IBA 12/2023 - 06/2014
3	ProgranulinsIBA 05/2022 - 01/2018
3	Transcription Factors (Transcription Factor)IBA 01/2022 - 01/2011
3	LigandsIBA 01/2022 - 04/2018
3	RNA (Ribonucleic Acid)IBA 01/2020 - 01/2014
3	Androgen Antagonists (Antiandrogens)IBA 07/2015 - 08/2012
2	enfortumab vedotinIBA 01/2024 - 01/2023
2	Immunoconjugates (Immunoconjugate)IBA 01/2024 - 01/2023
2	InterferonsIBA 01/2023 - 02/2007
2	Cell-Free Nucleic AcidsIBA 11/2022 - 11/2021
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2022 - 02/2013
2	C-Reactive ProteinIBA 01/2022 - 11/2019
2	Programmed Cell Death 1 ReceptorIBA 01/2021 - 01/2020
2	Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA 01/2021 - 11/2020
2	PlatinumIBA 01/2020 - 12/2019
2	N,N'- bis(2- hydroxy- 5- (ethylene- beta- carboxy)benzyl)ethylenediamine N,N'-diacetic acidIBA 10/2019 - 10/2018
2	gallium 68 PSMA-11IBA 10/2019 - 10/2018
2	Urokinase Plasminogen Activator ReceptorsIBA 06/2019 - 09/2015
2	Tumor Biomarkers (Tumor Markers)IBA 01/2019 - 10/2008
2	technetium 99m 1- (1- (2- (bis(carboxymethyl)amino)- 2- oxoethyl)- 1H- imidazol- 2- yl)- 2- ((1- (2- (bis(carboxymethyl)amino)- 2- oxoethyl)- 1H- imidazol- 2- yl)methyl)- 9,14- dioxo- 2,8,13,15- tetraazaoctadecane- 7,12,16,18- tetracarboxylic acid)IBA 08/2018 - 04/2018
2	CardenolidesIBA 02/2017 - 10/2015
2	3- (2- (1- amantadine)- 1- one- ethylamine)digitoxigeninIBA 02/2017 - 10/2015
2	ethylamineIBA 02/2017 - 10/2015
2	Amantadine (Aman)FDA LinkGeneric 02/2017 - 10/2015
2	Digitoxin FDA Link 02/2017 - 10/2015
2	DigitoxigeninIBA 02/2017 - 10/2015
2	Gonadotropin-Releasing Hormone (GnRH)FDA Link 11/2015 - 07/2015
2	WD repeat containing planar cell polarity effectorIBA 10/2015 - 01/2013
2	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2015 - 05/2003
2	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 12/2014 - 01/2014
2	Cadherins (E-Cadherin)IBA 07/2013 - 03/2010
2	Retroelements (Retrotransposon)IBA 02/2007 - 01/2006
1	NectinsIBA 01/2024
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2024
1	sacituzumab govitecanIBA 01/2024
1	Decitabine FDA Link 01/2023
1	antineoplaston A10 (A 10)IBA 01/2023
1	MethyltransferasesIBA 01/2023
1	Cytotoxins (Cytolysins)IBA 01/2023
1	Tyrosine Kinase InhibitorsIBA 09/2022

Therapy/Procedure

41	Therapeutics 09/2023 - 12/2002
24	Cystectomy 01/2023 - 12/2002
10	Drug Therapy (Chemotherapy) 01/2021 - 12/2002
9	Prostatectomy (Retropubic Prostatectomy) 01/2023 - 05/2003
6	Adjuvant Chemotherapy 01/2021 - 07/2011
5	Kidney Transplantation 02/2024 - 01/2013
4	Immunotherapy 01/2023 - 04/2010
4	Transurethral Resection of Bladder 04/2022 - 07/2012
4	Chemoradiotherapy 12/2019 - 03/2011
4	Radiotherapy 12/2019 - 11/2006
3	Nephrectomy 10/2021 - 03/2010
2	Orchiectomy (Orchidectomy) 01/2023 - 11/2006
2	Transplantation 01/2022 - 10/2013
2	Nephroureterectomy 01/2017 - 07/2015
2	Castration 07/2015 - 06/2014
1	Urinary Diversion (Ileal Conduit) 02/2024
1	General Anesthesia 12/2023
1	Medication Errors (Medication Error) 08/2022